Flamma, a group cGMP & FDA inspected facilities,  is a CDMO group offering the opportunity to accelerate small molecule drug development by shortening the timeline to the pharmaceutical marketplace. Flamma provides a stable, secure supply chain for small molecule Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCEs), Registered Starting Materials (RSMs) and Key Intermediates from early-stage needs to commercial delivered materials.